Objectives: Chronic conditions, like CF, have a significant influence on young patients' quality of life. As these diseases cannot (yet) be cured, it transforms health-care's primary focus from acute treatment to the minimization of risks for complications, and attempts to empower patients to deal with their condition in everyday life. Involving adolescents in their own care proves to be extremely difficult. For example, it is estimated that adolescent patients adhere to only half of their lifestyle and medication regimens in a way that they obtain optimal clinical benefit. In this study, we tried to get more insight into the difficulties of living with a condition like CF. Methods: An explorative, qualitative study. For 4 weeks, 18 health-professionals followed a regimen based on treatment guidelines for adolescent patients with CF, including nebulisation, oral medication, journal keeping, rest and sports activities. Conclusion: The participants' main difficulties were constantly 'feeling different than others' and having to be cautious and illness-aware in every-day situations. Although a motivated and very knowledgeable group of pediatric professionals volunteered to participate they found it surprisingly difficult to adhere to the lifestyle and medication regimen they expected their patients to follow. Recommendations to improve compliance in adolescents with CF are presented. and 2008-2011 (Group 2, n = 41). The differences in lung function, nutritional status, microbiological status, treatment intensity and age at transition between the groups were compared. Results: For Group 1, mean (SD) FEV1% predicted and BMI z scores were 68% (22) and −0.46 (1.0) compared to Group 2 of 75% (25) and −0.23 (1.), respectively. Group 1 had a greater proportion of children with chronic S. aureus infection (p = 0.005). Group 2 had a higher proportion receiving Azithromycin (p < 0.001), nebulised Colomycin and/or Tobramycin (p = 0.026) and DNase (p = 0.039). Median age at transition was significantly higher in Group 2 (17.02 compared to 16.6 years, p < 0.001).
Conclusion:
Over the past 10 years, there has been a trend towards improvement in FEV1% and BMI z scores, although this did not reach statistical significance. The burden of care for adolescents transitioning today may be greater due to the intensity of the treatment regimen. The older age at transition may be related to the acknowledgement that the transition process requires time and preparation. Objectives: The limited number of neuropsychological studies in children with Cystic Fibrosis (CF) focus primarily on intelligence and school performance. Little is known about social cognition and executive functioning (EF), essential for normal development and daily functioning. The aim of this study was to measure social cognition and related functions in children with CF aged 5 to 13 years and to compare these to normative data. Methods: Participants: 20 CF patients from 2 CF centers in the Netherlands. Outcome variables: a standardized neuropsychological battery including tests on social cognition (emotion recognition and theory of mind), EF (planning, working memory and cognitive flexibility) and intelligence; questionnaires on EFcompleted by parents and teachers; indices of disease severity (Forced Expiratory Volume in 1 second, BMI, exacerbations per year). Analysis: Analysis was performed with nonparametric procedures. Results: Patients' average performance on tests of social cognition, EF and IQ did not significantly differ from normative data. Comparisons to a healthy control group will be presented additionally. Although ratings on EF were in the normal range, teachers indicated significantly more problems than parents on scales of behavioural regulation and metacognition. Disease severity was not significantly related to any of the cognitive variables. Conclusion: Based on this Dutch CF sample, we may conclude that performance on social cognitive, executive and IQ tests is within the normal range and seems unrelated to disease severity. This is in concordance with the sparse publications on other neurocognitive functions in these patients.
